Maintenance fees coming due

Eyepoint, Inc.

7 maintenance fees come due in the 12 months from Nov 14, 2026, the next on Dec 6, 2026. Unpaid by Jun 7, 2027, that one lapses early.

A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.

Patent	Title	Holder	Status	Fee due	Lapses if unpaid	Expires	Confidence
US 11,666,558	Methods of Treating Intraocular Pressure with Activators of TIE-2 Eyepoint, Inc. In force Fee due Dec 6, 2026 Lapses if unpaid Jun 7, 2027 Term ends Sep 22, 2036 · High confidence	Eyepoint, Inc.	In force	Dec 6, 2026	Jun 7, 2027	Term ends Sep 22, 2036	High confidence
US 10,329,357	Treatment of Ocular Disease Eyepoint, Inc. In force Fee due Dec 25, 2026 Lapses if unpaid Jun 25, 2027 Term ends Oct 15, 2032 · Medium confidence	Eyepoint, Inc.	In force	Dec 25, 2026	Jun 25, 2027	Term ends Oct 15, 2032	Medium confidence
US 9,174,950	Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells Eyepoint, Inc. In force Fee due May 3, 2027 Lapses if unpaid Nov 3, 2027 Term ends Jan 12, 2030 · High confidence	Eyepoint, Inc.	In force	May 3, 2027	Nov 3, 2027	Term ends Jan 12, 2030	High confidence
US 11,873,334	Method of Treating Ocular Conditions by Administering an Antibody That Activates TIE2 and Binds VEGF Eyepoint, Inc. In force Fee due Jul 16, 2027 Lapses if unpaid Jan 18, 2028 Term ends Sep 23, 2039 · High confidence	Eyepoint, Inc.	In force	Jul 16, 2027	Jan 18, 2028	Term ends Sep 23, 2039	High confidence
US 10,597,452	Methods of Treating Ocular Conditions by Administering Humanized Monoclonal Antibodies That Target Ve-Ptp (HPTP-BETA) Eyepoint, Inc. In force Fee due Sep 24, 2027 Lapses if unpaid Mar 24, 2028 Term ends Jul 19, 2037 · High confidence	Eyepoint, Inc.	In force	Sep 24, 2027	Mar 24, 2028	Term ends Jul 19, 2037	High confidence
US 10,604,569	Humanized Monoclonal Antibodies That Target Protein Tyrosine Phosphatase-Beta (Hptp-Beta / Ve-Ptp) Eyepoint, Inc. In force Fee due Sep 30, 2027 Lapses if unpaid Mar 31, 2028 Term ends Jul 19, 2037 · High confidence	Eyepoint, Inc.	In force	Sep 30, 2027	Mar 31, 2028	Term ends Jul 19, 2037	High confidence
US 9,333,173	Bioerodible Silicon-Based Devices for Delivery of Therapeutic Agents Eyepoint, Inc. In force Fee due Nov 10, 2027 Lapses if unpaid May 10, 2028 Term ends Mar 29, 2032 · High confidence	Eyepoint, Inc.	In force	Nov 10, 2027	May 10, 2028	Term ends Mar 29, 2032	High confidence

7 of 7 patents shown. Soonest fee due date first, then patent number.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.